We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$670M
AUM Growth
+$172M
Cap. Flow
+$37.5M
Cap. Flow %
5.59%
Top 10 Hldgs %
63.01%
Holding
164
New
62
Increased
39
Reduced
20
Closed
34

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.49M
2
CNVS icon
Cineverse
CNVS
+$6.05M
3
SHIP icon
Seanergy Maritime Holdings
SHIP
+$5.68M
4
RMTI icon
Rockwell Medical
RMTI
+$5.66M
5
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$5.55M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.6M
2
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$10.7M
3
XERS icon
Xeris Biopharma Holdings
XERS
+$2.89M
4
PLLL
Piedmont Lithium Limited American Depositary Receipts
PLLL
+$2.88M
5
ALNA
Allena Pharmaceuticals
ALNA
+$2.42M

Sector Composition

Rank Sector Weight
1 Healthcare 12.1%
2 Technology 0.73%
3 Industrials 0.54%
4 Communication Services 0.41%
5 Consumer Staples 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
CALL
Biogen
BIIB
$30.4B
$95.1M 14.2%
3,354
+1,550
+86% +$432K
BIIB icon
2
PUT
Biogen
BIIB
$30.4B
$66.9M 9.99%
2,359
-185
-7% -$51.6K
XLV icon
3
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$48.9M 7.3%
4,634
– –
OEF icon
4
PUT
iShares S&P 100 ETF
OEF
$19.8B
$45.3M 6.76%
3,111
+157
+5% +$24.1K
TSLA icon
5
CALL
Tesla
TSLA
$1.21T
$36.5M 5.44%
+2,550
New +$301K
SPY icon
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$31.2M 4.65%
931
+321
+53% +$106K
MRNA icon
7
PUT
Moderna
MRNA
$22.1B
$29.5M 4.41%
4,172
+1,257
+43% +$87.6K
SPY icon
8
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$29M 4.33%
867
+306
+55% +$101K
TSLA icon
9
PUT
Tesla
TSLA
$1.21T
$21.4M 3.2%
+1,305
New +$154K
OEF icon
10
CALL
iShares S&P 100 ETF
OEF
$19.8B
$18.3M 2.73%
1,239
– –
AZN icon
11
PUT
AstraZeneca
AZN
$267B
$16.9M 2.52%
1,538
+1,200
+355% +$133K
XNTK icon
12
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2B
$14.9M 2.22%
1,337
-976
-42% -$110K
BIIB icon
13
Biogen
BIIB
$30.4B
$12.6M 1.89%
44,536
-59,366
-57% -$16.6M
CVM.WS
14
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
$9.91M 1.48%
7,773
+4,689
+152% +$5.98M
XLV icon
15
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$8.8M 1.31%
834
+168
+25% +$17.7K
MRNA icon
16
Moderna
MRNA
$22.1B
$8.63M 1.29%
121,975
+50,082
+70% +$3.49M
AZN icon
17
AstraZeneca
AZN
$267B
$8.11M 1.21%
73,973
+58,313
+372% +$6.49M
SRNE
18
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$7.96M 1.19%
7,143
-2,938
-29% -$26.9K
MRNA icon
19
CALL
Moderna
MRNA
$22.1B
$7.73M 1.15%
1,092
+934
+591% +$65.1K
BCLI
20
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$7.52M 1.12%
296
-326
-52% -$66.8K
SRNE
21
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$6.76M 1.01%
+606,298
New +$5.55M
PFE icon
22
CALL
Pfizer
PFE
$144B
$6.67M 1%
+1,915
New +$67.1K
PLUR icon
23
PUT
Pluri
PLUR
$18.1M
$6.3M 0.94%
748
-19
-2% -$1.45K
CVM.WS
24
CALL
DELISTED
Cel-Sci Corp Series S
CVM.WS
$5.87M 0.88%
4,605
+2,646
+135% +$3.37M
KYNB
25
PUT
Kyntra Bio
KYNB
$28.2M
$5.83M 0.87%
57
+1
+2% +$1.08K
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2020 Portfolio in Review

As of Q3 2020, Sabby Management held 164 positions worth $670M, up 34% from $498M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sabby Management deployed $37.5M of net new capital in Q3 2020, opening 62 new positions and adding to 39 existing holdings. Its largest new stake was Cineverse: 243,797 shares worth $2.75M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Biogen, an estimated $16.6M trimmed.

  • Sabby Management's largest Q3 2020 buy was Cineverse: 243,797 shares worth $2.75M.
  • Sabby Management added most to AstraZeneca in Q3 2020, an estimated $6.49M increase.
  • Sabby Management's biggest Q3 2020 reduction was Biogen, cutting an estimated $16.6M.
  • Sabby Management fully exited Xeris Biopharma Holdings in Q3 2020, selling an estimated $2.89M.
  • Sabby Management's ten largest holdings make up 63% of its $670M portfolio in Q3 2020.
  • Sabby Management opened 62 new positions and closed 34 in Q3 2020.
  • Sabby Management's portfolio value rose 34% quarter-over-quarter to $670M.

Based on Sabby Management's 13F filing for Q3 2020, filed 16 Nov 2020.